Coursera Inc. (NYSE:COUR) is one of the most promising mid-cap consumer staples stocks under $100.
On January 5, RBC Capital Markets analyst Rishi Jaluria reiterated his optimism on Coursera Inc. (NYSE:COUR), maintaining an Outperform rating on the stock. He lowered his price target from $13 to $11, which still results in an upside of almost 51%.
Rawpixel.com/Shutterstock.com
Jaluria expects 2026 to be driven by AI-related catalysts, which will help businesses that have positioned themselves to capitalize on such developments. He emphasized on certain peers, who have not prepared themselves for such disruptions, to struggle with the “AI is the death of software” narrative. Despite some conservatism in early 2026 guidance, the analyst noted GenAI-related innovation trends and related enterprise spending in specific areas.
On December 17, Nafeesa Gupta of Bank of America Securities maintained a neutral rating on Coursera Inc. (NYSE:COUR). Her estimated target price of $12 leads to an upside potential of almost 65% for investors.
Gupta attributed her stance to the company’s global user base and an extensive ecosystem of complementary content. She also highlighted how the company’s proprietary platform is set to capitalize on AI-driven developments, which will transform the online learning experience for users. Gupta also shared the company’s forward-looking EV/2026E Sales multiple of 1.4x, which led to her estimated $12 price target.
Coursera Inc. (NYSE:COUR) is an online course provider that collaborates with universities and training institutions to deliver virtual degrees, certifications, and online training programs. Their operations are stretched across 3 segments, i.e., Consumer, Enterprise, and Degrees, and are being delivered to users around the world. They cater to the needs of individuals, organizations, and government entities.
While we acknowledge the potential of COUR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.
Disclosure: None. This article is originally published at Insider Monkey.
